IRIS
MISSO, Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.918
NA - Nord America 3.318
AS - Asia 2.485
SA - Sud America 333
AF - Africa 35
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.095
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.957
US - Stati Uniti d'America 3.280
SG - Singapore 792
IE - Irlanda 556
CN - Cina 533
IT - Italia 436
VN - Vietnam 397
BR - Brasile 291
HK - Hong Kong 276
DE - Germania 220
GB - Regno Unito 212
UA - Ucraina 189
KR - Corea 148
JP - Giappone 105
FI - Finlandia 78
FR - Francia 65
IN - India 64
TR - Turchia 57
GR - Grecia 56
SE - Svezia 31
PK - Pakistan 27
AT - Austria 18
PL - Polonia 16
BE - Belgio 15
CA - Canada 15
ES - Italia 13
IR - Iran 12
MX - Messico 12
NL - Olanda 12
ZA - Sudafrica 12
CO - Colombia 11
CZ - Repubblica Ceca 11
ID - Indonesia 11
AR - Argentina 10
BD - Bangladesh 10
IQ - Iraq 8
LT - Lituania 7
UZ - Uzbekistan 7
EC - Ecuador 6
MA - Marocco 6
BG - Bulgaria 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CH - Svizzera 4
CL - Cile 4
CR - Costa Rica 4
IL - Israele 4
PY - Paraguay 4
SA - Arabia Saudita 4
TN - Tunisia 4
TW - Taiwan 4
KE - Kenya 3
PH - Filippine 3
SC - Seychelles 3
TH - Thailandia 3
VE - Venezuela 3
AL - Albania 2
BO - Bolivia 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
HU - Ungheria 2
JM - Giamaica 2
KZ - Kazakistan 2
MD - Moldavia 2
NP - Nepal 2
RO - Romania 2
RS - Serbia 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
HN - Honduras 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
MG - Madagascar 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SN - Senegal 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
UY - Uruguay 1
Totale 12.095
Salva come PNG Salva come JPEG
Città #
Moscow 1.475
Dallas 564
Dublin 556
Singapore 392
San Jose 336
Santa Clara 324
Chandler 308
Jacksonville 300
Hong Kong 272
Ashburn 188
Seoul 145
Ho Chi Minh City 108
Beijing 92
Hefei 82
Ann Arbor 81
New York 80
Hanoi 78
Dong Ket 72
Princeton 69
Naples 65
Bremen 61
Medford 61
Roxbury 53
Boardman 51
Caserta 42
Bengaluru 40
Aversa 38
Woodbridge 36
Los Angeles 32
Munich 30
Wilmington 29
Des Moines 27
São Paulo 27
The Dalles 23
Da Nang 22
Helsinki 20
San Mateo 20
Napoli 19
Nuremberg 19
Warsaw 16
Brussels 15
Milan 15
Mountain View 15
Orem 15
Falkenstein 14
Istanbul 12
Brno 11
Cambridge 11
Council Bluffs 11
Haiphong 11
Rome 10
San Nicola la Strada 10
Johannesburg 9
London 9
Rio de Janeiro 9
Tianjin 9
Vienna 9
Zhengzhou 9
Bahawalpur 8
Brasília 8
Brooklyn 8
Chennai 8
Falls Church 8
Frankfurt am Main 8
San Francisco 8
Tokyo 8
Cava Dei Tirreni 7
Düsseldorf 7
Houston 7
Lappeenranta 7
Mexico City 7
Piscataway 7
Belo Horizonte 6
Biên Hòa 6
Boston 6
Curitiba 6
Guangzhou 6
Nanjing 6
Viterbo 6
Amsterdam 5
Auburn Hills 5
Avellino 5
Denver 5
Jakarta 5
Madrid 5
Manchester 5
Montreal 5
Paris 5
Phủ Lý 5
Phủ Từ Sơn 5
Shenzhen 5
Changsha 4
Chicago 4
Ercolano 4
Fortaleza 4
Goiânia 4
Guarulhos 4
Gunzenhausen 4
Hangzhou 4
Kyiv 4
Totale 6.701
Salva come PNG Salva come JPEG
Nome #
Comparative study of NGS platform ion torrent personal genome machine and therascreen rotor-gene Q for the detection of somatic variants in cancer. 244
Mitochondria as playmakers of apoptosis, autophagy and senescence 196
"Phase II trial of bevacizumab and dose/dense chemoterapy with cisplatin and metronomic daily oral etoposide in advanced non small cell lung cancer patients" 189
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells 188
A miRNA signature suggestive of nodal metastases from laryngeal carcinoma. 188
A hydroquinone-based derivative elicits apoptosis and autophagy via activating a ros-dependent unfolded protein response in human glioblastoma 183
Long-term neuropathic pain behaviors correlate with synaptic plasticity and limbic circuit alteration: a comparative observational study in mice 183
Prognostic value of EGFR and EGFR-MEDIATED transduction signal inhibition: effective therapeutic strategies in the management of laryngeal cancer 179
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 171
Poorly differentiated neuroendocrine larynx carcinoma: Clinical features and mirnas signature—a new goal for early diagnosis and therapy? 169
Definition of miRNA Signatures of Nodal Metastasis in LCa: miR-449a Targets Notch Genes and Suppresses Cell Migration and Invasion 164
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma 163
W7FW14F apomyoglobin amyloid aggregates-mediated apoptosis is due to oxidative stress and AKT inactivation caused by Ras and Rac 163
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 162
MicroRNAs’ Crucial Role in Salivary Gland Cancers’ Onset and Prognosis 161
Definition of microRNAs predictive of nodal involvement in laringeal cancer patients 160
MiR-449a antagonizes EMT through IL-6-mediated trans-signaling in laryngeal squamous cancer 158
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer 158
Cytotoxic drugs up-regulate Epidermal Growth Factor Receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted Antibody-Dependent-Cell-mediated-Cytotoxicity (ADCC) 158
Gene interference strategies as a new tool for the treatment of prostate cancer 158
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action 157
Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem 154
Immune cell infiltration and inflammatory landscape in primary brain tumours 153
Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicity. 153
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus 153
Combined use of free light chain and heavy/light chain ratios allow diagnosis and monitoring of patients with monoclonal gammopathies: Experience of a single institute, with three exemplar case reports 151
Exosomes multiplex profiling, a promising strategy for early diagnosis of laryngeal cancer 150
Bisphosphonates and cancer: what opportunities from nanotechnology? 150
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 150
Biosensore per rivelazione di firma molecolare di miRNA ad interesse diagnostico in patologie umane 146
microRNA Detection via Nanostructured Biochips for Early Cancer Diagnostics 145
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model 145
Molecular markers as a new tool for diagnostic and prognostic definition of type 2 diabetes mellitus 144
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model 142
Identification and bioinformatic characterization of a serum miRNA signature for early detection of laryngeal squamous cell carcinoma 139
Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma 138
Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey. 138
Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev) 138
Emerging strategies to strengthen the anti-tumour activity of type I IFNs: overcoming survival pathways 136
Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid. 136
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 136
Emerging pathways as individualized therapeutic target of multiple myeloma. 134
Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems 133
Flexible 3D nanofiber-based SERS biosensor for detection of miRNA-223-3p in early Laryngeal Cancer diagnosis 132
Tumour-specific uptake of anti-cancer drugs: the future is here. 131
Nanoparticelle e loro usi 130
Possible roles of transglutaminases in molecular mechanisms responsible for cancer and human neurodegenerative diseases. 130
Possible antioxidant role of SPA therapy with chlorine-sulphur-bicarbonate mineral water. 129
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment 129
Transferrin-Conjugated SNALPs Encapsulating 2'-O-Methylated miR-34a for the Treatment of Multiple Myeloma 126
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 124
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 123
High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy. 122
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses 122
Insight toward the microRNA profiling of laryngeal cancers: Biological role and clinical impact 122
Tissue expression of miR-449a as risk factor for occult neck metastasis in patients with cT3-T4 N0 laryngeal cancer. A pilot study 121
Optimal Management of Prostate Cancer Based on its Natural Clinical History 121
Myrtucommulone production by a strain of Neofusicoccum australe endophytic in myrtle (Myrtus communis). 119
MOLECULAR TARGETS FOR THE TREATMENT OF MULTIPLE MYELOMA 119
Measurement of autophagy by flow cytometry 119
Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum 119
Immune-modulating Effects of the Newest Cetuximab-based Chemoimmunotherapy Regimen in Advanced Colorectal Cancer Patients. 118
Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC. 118
Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer Treatment 117
Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours 117
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. 116
Mir-34: a new weapon against cancer? 116
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics 115
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin 115
In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma. 114
Early detection of laryngeal cancer: prominence of miRNA signature as a new tool for clinicians 113
Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: The GOLFIG-2 multicentric open-label randomized phase III trial 112
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer 111
Lipid Nanoparticles to Deliver miRNA in Cancer 110
Role of perineural invasion as a prognostic factor in laryngeal cancer 110
Synergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell lines 110
Zoledronic acid affects the cytotoxic effects of Chlamydia pneumoniae and the modulation of cytokine production in human osteosarcoma cells. 109
The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response 105
Hepatocarcinoma: genetic and epigenetic features 105
MICRO-RNAs as biological markers for prevention and diagnosis of oral carcinomas 101
Non-coding RNAs as a new dawn in tumor diagnosis 98
Therapeutic targeting of miR-29b/HDAC4 epigenetic loop in multiple myeloma 96
Interleukin-2 and lanreotide in the treatment of medullary thyroid cancer: in vitro and in vivo studies. 95
Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review 94
Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research 93
Safety and efficacy evaluation in vivo of a cationic nucleolipid nanosystem for the nanodelivery of a ruthenium(Iii) complex with superior anticancer bioactivity 91
Aminobisphosphonates and nano technologically-modified aminobisphosphonates: A new dawn in the treatment of bone and extra-bone tumors? 90
Prognostic patterns for predicting lymph node metastasis in patients with squamous cell carcinoma of the larynx 89
Genetic landscape of colorectal cancer patients manifesting tumor shrinkage during SARS-Cov-2 infection 88
Proteomic profiling identifies miR-423-5p as a modulator of oncogenic metabolism in HCC 87
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem 86
Complex genetic landscape in CLL: Clinical impact on patients’ survival and insights into the altered molecular pathways 80
MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interaction 77
Totale 12.350
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.159
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.159
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021183 0 0 0 0 0 0 0 0 0 42 61 80
2021/2022444 23 12 1 7 147 11 6 14 18 25 43 137
2022/20231.138 125 19 18 118 104 121 4 63 506 19 23 18
2023/2024645 35 15 90 29 148 82 7 23 37 9 46 124
2024/20251.464 27 31 6 85 232 195 209 119 226 117 123 94
2025/20267.147 280 388 859 281 568 3.671 384 334 188 194 0 0
Totale 12.350